Mutations of p53 Tumor Suppressor Gene, Apoptosis, and Proliferation in Intrahepatic Cholangiocellular Carcinoma of the Liver (original) (raw)
REFERENCES
Wittekind C: Hepatocellular carcinoma. In: Prognostic Factors in Cancer. P Hermanek, MK Gospodarowicz, DE Henson, RVP Hutter, LH Sobin (eds). Heidelberg, Springer, 1995, pp 88-93 Google Scholar
Banerjee B, Teplick SK: Nonsurgical management of primary cholangiocarcinoma. Retrospective analysis of 40 cases. Dig Dis Sci 40:701-705, 1995 Google Scholar
Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, Yoshimura A, Ko S, Kin T, Yagura K, Konishi Y, Nakano H: Ki-ras mutations and p53 protein expression in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology. Gastroenterology 109:1612-1617, 1995 Google Scholar
Tada M, Omata M, Ohto M: High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer 69:1115-1118, 1992 Google Scholar
Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M, Yoshida J, Sakamoto M, Hirohashi S, Yamasaki S, Hasegawa H: Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery 111:617-622, 1992 Google Scholar
Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R: What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 79:26-34, 1997 Google Scholar
Kiba T, Tsuda H, Pairokjul C, Inoue S, Sugimura T, Hirohashi S: Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocarcinomas in Japan and Thailand. Mol Carcinogen 8:312-318, 1993 Google Scholar
Harris CC: Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1455, 1996 Google Scholar
WHO: Histological Typing of Tumours of the Liver, 2nd ed. T Ishak (ed). Berlin, Springer, 1994 Google Scholar
UICC: TNM Classification of Malignant Tumors. 5th ed. LH Sobin, C Wittekind (eds). New York, Wiley-Liss, 1997 Google Scholar
Ohashi K, Nakajima Y, Tsutsumi M, Kanehiro H, Fukuoka T, Hisanaga M, Takai J, Nakae D, Konishi Y, Nakano H: Clinical characteristics and proliferating activity in intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol 9:442-446, 1994 Google Scholar
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1989, pp E3-E4 Google Scholar
Tannapfel A, Hahn HH, Katalinic A, Fietkau R, Kühn R, Wittekind C. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 77:164-171, 1996 Google Scholar
Aubele M, Biesterfeld S, Derenzini M, Hufnagl P, Martin H, Öfner D, Ploton D, Rüschoff J: Guidelines of AgNOR quantitation. Zentrbl Pathol 140:107-108, 1994 Google Scholar
Tannapfel A, Geissler F, Köckerling F, Katalinic A, Hauss J, Wittekind C: Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathol (in press)
Grigioni WF, Dèrrico A, Bacci F, Gaudio M, Mazziotti A, Gozzetti G, Mancini AM: Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67. J Pathol 158:23-29, 1989 Google Scholar
Zhao G, Su S, Borek D, Friesen S, Halmes F: Long survival and prognostic factors in hepatocellular carcinoma. J Surg Oncol 45:257-260, 1990 Google Scholar
Delhaye M, Louis H, Degraef C, LeMoine O, Devièe J, Gulbis B, Jacobovitz D, Adler M, Galand P: Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology 23:1003-1011, 1996 Google Scholar
Nagao T, Ishida Y, Yamazaki K, Kondo Y: Nucleolar organizer regions in hepatocellular carcinoma is related to the cell cycle, cell proliferation and histologic grade. Pathol Res Pract 191:967-972, 1995 Google Scholar
Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR: Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. Am J Pathol 116:441-446, 1984 Google Scholar
Terada T, Nakanuma Y: Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens [bcl-2, c-myc, Fas, Lewis (y) and p53] in human cholangiocarcinomas and hepatocellular carcinomas. Pathol Int 46:767-770, 1996 Google Scholar
Nzeako U, Goodman ZD, Ishak KG: Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 76:579-588, 1995 Google Scholar
Soini Y, Virkajarvi N, Lehto VP, Paako P: Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 73:1025-1030, 1996 Google Scholar
Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 6358-6364, 1992
Janssen YM, VanHouten B, Borm PJ, Mossman BT: Cell and tissue responses to oxidative damage. Lab Invest 69:261-274, 1993 Google Scholar
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J: Molecular biology of colorectal cancer. Curr Probl Cancer 21:233-300, 1997 Google Scholar
Hollstein M, Shomer B, Greenblatt M: Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation. Nucleic Acids Res 24:141-146, 1996 Google Scholar